Storys aus Aachen-

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

FEV Group

FEV and ProLogium develop high-performance vehicle battery

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Fraunhofer-Institut für Produktionstechnologie IPT

2

Deep learning for real-time quality control: Aachen-based Fraunhofer Institutes improve defect detection in weld seams

Grünenthal Group

Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer

Fraunhofer-Institut für Produktionstechnologie IPT

Life cycle assessment for energy-efficient and climate-friendly optics production

Grünenthal Group

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...

Grünenthal Group

2

Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients

Fraunhofer-Institut für Produktionstechnologie IPT

5G Industry Campus Europe in Aachen expanded with Cloud RAN

Fraunhofer-Institut für Produktionstechnologie IPT

Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer study report describes AI use cases and sustainable energy concepts

Fraunhofer-Institut für Produktionstechnologie IPT

Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems

Grünenthal Group

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...

Grünenthal Group

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer IPT conducts research into automated series production of optics with new glass press

Grünenthal Group

Grünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration

Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer study report on cybersecurity, digital twins and sustainability in production

Fraunhofer-Institut für Produktionstechnologie IPT

Joint expertise from industry and research: New regulations standardize optical coherence tomography

Fraunhofer-Institut für Produktionstechnologie IPT

Go-ahead for 6G in industry: EU funds technology development with more than 13 million euros

Fraunhofer-Institut für Produktionstechnologie IPT

Fraunhofer IPT manufactures super-lightweight frame for experiments in outer space

Accure

HDI TH!NX makes battery reliability insurable on the basis of ACCURE battery analytics

Accure

BVG Trials ACCURE’s Battery Safety Monitoring System on Electric Buses

Accure

ACCURE exceeds 1,111 megawatt-hours of monitored battery systems with battery-powered boats from Soel Yachts and Naval DC